374 results on '"Winship, Ingrid M."'
Search Results
52. Cancer risk and tumour spectrum in 172 patients with a germlineSUFUpathogenic variation: a collaborative study of the SIOPE Host Genome Working Group
53. Evaluating multiple next-generation sequencing derived tumor features to accurately predict DNA mismatch repair status
54. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome
55. Additional file 1 of Body Mass Index, sex, non-steroidal anti-inflammatory drug medications, smoking and alcohol are differentially associated with World Health Organisation criteria and colorectal cancer risk in people with Serrated Polyposis Syndrome: an Australian case-control study
56. Additional file 1 of Heterogeneity in the psychosocial and behavioral responses associated with a diagnosis of suspected Lynch syndrome in women with endometrial cancer
57. Additional file 1 of Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM
58. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts
59. Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals
60. Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome
61. Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer
62. Genetic Diversity and Linkage Disequilibrium in the Polynesian Population of Niue Island
63. Fertility and apparent genetic anticipation in Lynch syndrome
64. Lynch syndrome and cervical cancer
65. A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium
66. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios
67. Update of penetrance estimates in Birt-Hogg-Dubé syndrome
68. Germline mutations in WNK2could be associated with serrated polyposis syndrome
69. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome
70. A step forward, but still inadequate: Australian health professionals' views on the genetics and life insurance moratorium.
71. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
72. DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer
73. Lessons from the skin—cutaneous features of familial cancer
74. Genetic testing in dementia‐A medical genetics perspective
75. Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry
76. Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer
77. Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome
78. Mainstreaming genomics: training experience of hospital medical officers at the Royal Melbourne Hospital
79. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers
80. Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review
81. Persistent Troponin Elevation in Left-Dominant Arrhythmogenic Cardiomyopathy
82. Renal Tumors and Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 4
83. The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program
84. Abstract A08: Tumor microbiome in subtypes of mismatch repair-deficient colorectal cancer
85. Germline and Tumor Whole Genome Sequencing as a Diagnostic Tool to Resolve Suspected Lynch Syndrome
86. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers
87. Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
88. X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats
89. An investigation into FOXE1 polyalanine tract length in premature ovarian failure
90. INHA promoter polymorphisms are associated with premature ovarian failure
91. Asthma phenotypes in Niue Islanders
92. Cancer risk and tumour spectrum in 172 patients with a germline SUFUpathogenic variation: a collaborative study of the SIOPE Host Genome Working Group
93. Family history–based colorectal cancer screening in Australia
94. Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome
95. Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-β
96. Clinico‐pathological predictors of mismatch repair deficiency in sebaceous neoplasia: A large case series from a single Australian private pathology service
97. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic
98. Maximizing the Clinical Benefit of DPYD Genotyping: Extending the Opportunity of Personalized Management to Family Members Through Cascade Testing
99. Insights into sudden cardiac death: exploring the potential relevance of non-diagnostic autopsy findings
100. Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.